Overview
Neema Negi practices practicing medicine in New Delhi, India.
Their clinical expertise encompasses HIV/AIDS, Alzheimer's Disease, Multiple Sclerosis (MS), and CACH Syndrome.
They are actively involved in clinical research, co-authoring 18 peer reviewed articles.
Locations
Delhi, DL, India
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Neema Negi
Is Neema Negi a top-rated expert for HIV/AIDS?
MediFind is an objective health platform that identifies experts based on real-world data. Neema Negi is classified as an Experienced expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Neema Negi participate in research or clinical trials?
Yes. Neema Negi has published 18 articles and abstracts on conditions like HIV/AIDS. You can view a list of Neema Negi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alzheimer's DiseaseNegi isExperienced. Learn about Alzheimer's Disease.
- CACH SyndromeNegi isExperienced. Learn about CACH Syndrome.
- DementiaNegi isExperienced. Learn about Dementia.
- HIV/AIDSNegi isExperienced. Learn about HIV/AIDS.
- Multiple Sclerosis (MS)Negi isExperienced. Learn about Multiple Sclerosis (MS).